Local appendiceal dysbiosis: The missing link between the appendix and ulcerative colitis?

Gut

Volumn 61, Issue 4, 2012, Pages 635-636

  Roblin, X ^a   Neut, C ^b   Darfeuille Michaud, A ^c   Colombel, J F ^d,e  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b UNIV LILLE   (France)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

^d UNIVERSITÉ DE LILLE   (France)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; METRONIDAZOLE; PLACEBO; TETRACYCLINE;

ACUTE APPENDICITIS; ANTIBIOTIC SENSITIVITY; APPENDECTOMY; APPENDICEAL DYSBIOSIS; APPENDIX DISEASE; BACTERIUM DETECTION; COLON PROTECTION; DISEASE ASSOCIATION; FLUORESCENCE IN SITU HYBRIDIZATION; FUSOBACTERIA; FUSOBACTERIUM NECROPHORUM; FUSOBACTERIUM NUCLEATUM; FUSOBACTERIUM PRAUSNITZII; FUSOBACTERIUM VARIUM; HUMAN; INTESTINE FLORA; LETTER; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTECTION; PROTEIN DEGRADATION; RISK REDUCTION; ULCERATIVE COLITIS;

APPENDICITIS; FUSOBACTERIUM INFECTIONS; FUSOBACTERIUM NECROPHORUM; FUSOBACTERIUM NUCLEATUM; HUMANS;

EID: 84857801101     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-300576     Document Type: Letter

References (8)

1. Swidsinski A, Dörffel Y, Loening-Baucke V, et al. Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut 2011;60:34-40.
2. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci 2008;105:16731-6.
3. Andersson RE, Olaison G, Tysk C, et al. Appendectomy and protection against ulcerative colitis. N Engl J Med 2001;344:808-14. (Pubitemid 32222158)
4. Frisch M, Pedersen BV, Andersson RE. Appendicitis, mesenteric lymphadenitis, and subsequent risk of ulcerative colitis: cohort studies in Sweden and Denmark. BMJ 2009;338:b716.
5. Cosnes J, Carbonnel F, Beaugerie L, et al. Effects of appendicectomy on the course of ulcerative colitis. Gut 2002;51:803-7. (Pubitemid 35408599)
6. Ohkusa T, Sato N, Ogihara T, et al. Fusobacterium varium localized in the colonic mucosa of patients with ulcerative colitis stimulates species-specific antibody. J Gastroenterol Hepatol 2002;17:849-53.
7. Minami M, Ando T, Okamoto A, et al. Seroprevalence of Fusobacterium varium in ulcerative colitis patients in Japan. FEMS Immunol Med Microbiol 2009;56:67-72.
8. Ohkusa T, Kato K, Terao S, et al. Newly developed antibiotic combination therapy for ulcerative colitis: a double-blind placebo-controlled multicenter trial. Am J Gastroenterol 2010;105:1820-9.